Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer

0.50 hr(s) | ABIM , CME , MOC , NCPD

Specialty: Endometrial Cancer , Gynecologic Cancer , Oncology

Therapeutic Area(s): Endometrial Cancer , Gynecology , Oncology

Release Date: April 27, 2022

Expiration Date: April 26, 2023

Location: Internet Enduring Activity

In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endometrial cancer.

Access this activity
Share via
Copy link
Powered by Social Snap